Christophe Hermans

1.0k total citations
32 papers, 649 citations indexed

About

Christophe Hermans is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Christophe Hermans has authored 32 papers receiving a total of 649 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 10 papers in Pulmonary and Respiratory Medicine and 9 papers in Molecular Biology. Recurrent topics in Christophe Hermans's work include Cancer Immunotherapy and Biomarkers (8 papers), Cancer Genomics and Diagnostics (4 papers) and Ferroptosis and cancer prognosis (3 papers). Christophe Hermans is often cited by papers focused on Cancer Immunotherapy and Biomarkers (8 papers), Cancer Genomics and Diagnostics (4 papers) and Ferroptosis and cancer prognosis (3 papers). Christophe Hermans collaborates with scholars based in Belgium, Netherlands and Spain. Christophe Hermans's co-authors include Christophe Deben, Marc Peeters, Evelien Smits, Patrick Pauwels, Filip Lardon, Julie Jacobs, Vanessa Deschoolmeester, Hilde Lambrechts, Vasiliki Siozopoulou and Jinthe Van Loenhout and has published in prestigious journals such as Blood, Cancer Research and Frontiers in Immunology.

In The Last Decade

Christophe Hermans

31 papers receiving 630 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christophe Hermans Belgium	16	256	230	139	119	118	32	649
Shuncong Wang China	16	209 0.8×	349 1.5×	75 0.5×	211 1.8×	98 0.8×	40	773
Ziqiang Zhu China	13	281 1.1×	182 0.8×	153 1.1×	77 0.6×	136 1.2×	31	609
Erwan Pencreach France	17	323 1.3×	350 1.5×	82 0.6×	200 1.7×	248 2.1×	35	797
Cecilie L. Bager Denmark	16	270 1.1×	267 1.2×	118 0.8×	120 1.0×	201 1.7×	35	937
Runzhe Chen China	14	144 0.6×	241 1.0×	85 0.6×	122 1.0×	67 0.6×	40	502
Jens Voortman Netherlands	19	427 1.7×	358 1.6×	110 0.8×	157 1.3×	151 1.3×	41	890
Joo Han Lim South Korea	18	335 1.3×	393 1.7×	69 0.5×	144 1.2×	163 1.4×	61	867
Hye Sook Chon United States	16	213 0.8×	222 1.0×	48 0.3×	112 0.9×	119 1.0×	68	680
Xiuling Li China	16	380 1.5×	207 0.9×	114 0.8×	40 0.3×	198 1.7×	46	788
Muxin Yu China	15	211 0.8×	175 0.8×	322 2.3×	82 0.7×	83 0.7×	31	697

Countries citing papers authored by Christophe Hermans

Since Specialization

Citations

This map shows the geographic impact of Christophe Hermans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christophe Hermans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christophe Hermans more than expected).

Fields of papers citing papers by Christophe Hermans

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christophe Hermans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christophe Hermans. The network helps show where Christophe Hermans may publish in the future.

Co-authorship network of co-authors of Christophe Hermans

This figure shows the co-authorship network connecting the top 25 collaborators of Christophe Hermans. A scholar is included among the top collaborators of Christophe Hermans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christophe Hermans. Christophe Hermans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Audenaerde, Jonas R.M. Van, Jorrit De Waele, Christophe Hermans, et al.. (2025). Co-targeting of VEGFR2 and PD-L1 promotes survival and vasculature normalization in pleural mesothelioma. OncoImmunology. 14(1). 2512104–2512104.

Hoz, Edgar Cardenas De La, Christophe Hermans, Andreas Domen, et al.. (2023). Single-organoid analysis reveals clinically relevant treatment-resistant and invasive subclones in pancreatic cancer. npj Precision Oncology. 7(1). 128–128. 15 indexed citations

Boullosa, Laurie Freire, Jinthe Van Loenhout, Tal Flieswasser, et al.. (2023). Auranofin Synergizes with the PARP Inhibitor Olaparib to Induce ROS-Mediated Cell Death in Mutant p53 Cancers. Antioxidants. 12(3). 667–667. 16 indexed citations

Pauw, Ines De, Christophe Hermans, Hilde Lambrechts, et al.. (2023). Establishment of head and neck squamous cell carcinoma mouse models for cetuximab resistance and sensitivity. Cancer Drug Resistance. 6(4). 709–28. 2 indexed citations

Flieswasser, Tal, Laurie Freire Boullosa, Christophe Hermans, et al.. (2023). Targeting CD70 in combination with chemotherapy to enhance the anti-tumor immune effects in non-small cell lung cancer. OncoImmunology. 12(1). 2192100–2192100. 6 indexed citations

Siozopoulou, Vasiliki, Christophe Hermans, Hilde Lambrechts, et al.. (2022). The prognostic impact of the immune signature in head and neck squamous cell carcinoma. Frontiers in Immunology. 13. 1001161–1001161. 13 indexed citations

Domen, Andreas, Christophe Deben, Ines De Pauw, et al.. (2022). Prognostic implications of cellular senescence in resected non-small cell lung cancer. Translational Lung Cancer Research. 11(8). 1526–1539. 29 indexed citations

Boullosa, Laurie Freire, Jinthe Van Loenhout, Christophe Hermans, et al.. (2022). Optimization of the Solvent and In Vivo Administration Route of Auranofin in a Syngeneic Non-Small Cell Lung Cancer and Glioblastoma Mouse Model. Pharmaceutics. 14(12). 2761–2761. 7 indexed citations

Boullosa, Laurie Freire, Jinthe Van Loenhout, Tal Flieswasser, et al.. (2021). Auranofin reveals therapeutic anticancer potential by triggering distinct molecular cell death mechanisms and innate immunity in mutant p53 non-small cell lung cancer. Redox Biology. 42. 101949–101949. 85 indexed citations

10.

Lammens, Martin, et al.. (2021). Efficacy and histopathological effects of self-assembling peptides RADA16 and IEIK13 in neurosurgical hemostasis. Nanomedicine Nanotechnology Biology and Medicine. 40. 102485–102485. 5 indexed citations

11.

Jacobs, Julie, Christophe Deben, Christophe Hermans, et al.. (2020). Mass Spectrometry Imaging Reveals Neutrophil Defensins as Additional Biomarkers for Anti-PD-(L)1 Immunotherapy Response in NSCLC Patients. Cancers. 12(4). 863–863. 19 indexed citations

12.

Cain, Stuart A., Peter Houpt, Frederik Verstreken, et al.. (2020). Delineation of a new fibrillin-2-opathy with evidence for a role of FBN2 in the pathogenesis of carpal tunnel syndrome. Journal of Medical Genetics. 58(11). 778–782. 7 indexed citations

13.

Siozopoulou, Vasiliki, Elly Marcq, Julie Jacobs, et al.. (2019). Desmoid tumors display a strong immune infiltration at the tumor margins and no PD-L1-driven immune suppression. Cancer Immunology Immunotherapy. 68(10). 1573–1583. 14 indexed citations

14.

Bossche, Jolien Van den, Christophe Deben, Ines De Pauw, et al.. (2019). In vitro study of the Polo‐like kinase 1 inhibitor volasertib in non‐small‐cell lung cancer reveals a role for the tumor suppressor p53. Molecular Oncology. 13(5). 1196–1213. 15 indexed citations

15.

Jacobs, Julie, Vanessa Deschoolmeester, Karen Zwaenepoel, et al.. (2018). Unveiling a CD70-positive subset of cancer-associated fibroblasts marked by pro-migratory activity and thriving regulatory T cell accumulation. OncoImmunology. 7(7). e1440167–e1440167. 45 indexed citations

16.

Boeckx, Nele, Ken Op de Beeck, Matthias Beyens, et al.. (2018). Mutation and Methylation Analysis of Circulating Tumor DNA Can Be Used for Follow-up of Metastatic Colorectal Cancer Patients. Clinical Colorectal Cancer. 17(2). e369–e379. 39 indexed citations

17.

Bossche, Jolien Van den, Christophe Deben, Ken Op de Beeck, et al.. (2017). Towards Prognostic Profiling of Non-Small Cell Lung Cancer: New Perspectives on the Relevance of Polo-Like Kinase 1 Expression, the TP53 Mutation Status and Hypoxia. Journal of Cancer. 8(8). 1441–1452. 12 indexed citations

18.

Corazza, Francis, Christophe Hermans, Alina Ferster, et al.. (2003). Bone Marrow Stroma Damage Induced by Chemotherapy for Acute Lymphoblastic Leukemia in Children. Pediatric Research. 55(1). 152–158. 21 indexed citations

19.

Dittrich, Christian, Bruno Coudert, Luis Paz‐Ares, et al.. (2003). Phase II study of XR 5000 (DACA), an inhibitor of topoisomerase I and II, administered as a 120-h infusion in patients with non-small cell lung cancer. European Journal of Cancer. 39(3). 330–334. 25 indexed citations

20.

Himpe, D., Hedwig Neels, Christophe Hermans, et al.. (1991). Priming solutions for cardiopulmonary bypass: Comparison of three colloids. Journal of Cardiothoracic and Vascular Anesthesia. 5(5). 457–466. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact